Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Acute NAION
NCT07330713Completed
- Sponsor
- Bursa Uludag University
- Start
- Jan 2022
- Primary completion
- Jan 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous platelet-rich plasma in non-arteritic anterior ischemic optic neuropathy (NAION) (2 arms), sponsored by Bursa Uludag University. Primary endpoint: Best-Corrected Visual Acuity at 16 weeks. Started Jan 2022; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on NCT07330713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07330713.